2 Bill Gates stocks to turn $100 into $1,000 by 2025

Group 1: Microsoft (MSFT) - Microsoft accounts for 32% of the Bill & Melinda Gates Foundation Trust's holdings, making it a significant investment for the Trust [2] - Wall Street analysts have a bullish outlook on MSFT, with an average price target of $504.91 for the next 12 months, representing a 21.04% increase from the current price [2] - Some analysts have set high-end price targets as high as $570, indicating a potential 37% increase from the current trading price of $415.70 [2] - MSFT is up 12.09% year-to-date (YTD) and 24.77% compared to the same time last year, despite a pullback in July due to underwhelming results in the cloud computing segment [3] - The stock price has shown stability, increasing by 0.33% on the daily chart and gaining 5.32% over the last month [3] Group 2: Schrodinger Inc (SDGR) - Schrodinger Inc comprises only 0.28% of the Trust's holdings and focuses on computational solutions for drug development [4] - Wall Street analysts predict a potential price increase of 54.54% for SDGR, with some targets suggesting a gain of 68.75% [4] - The company has seen a 3.7% revenue increase last quarter from its drug discovery platform, but it faces challenges with a 44% year-over-year revenue decline and a 13% increase in operating expenses [5] - Despite a 40.17% decline in share price YTD, SDGR maintains a strong financial position and has ongoing phase-1 clinical studies [5]